| Financial Year |
March 31 2022 |
| Monetary Funds |
402,145,602.51 |
| Held-for-trading Financial Assets |
51,900,000.00 |
| Notes Receivable |
94,166,572.72 |
| Accounts Receivable |
267,885,457.82 |
| Advances to Suppliers |
18,218,272.76 |
| Other Receivables |
6,263,410.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
286,925,560.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,608,533.80 |
| Total Current Assets |
1,175,074,718.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
327,901,238.65 |
| Under-construction Projects |
51,238,443.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,916,215.12 |
| R&D expenses |
-- |
| Goodwill |
7,432,203.43 |
| Long-Term Deferred and Prepaid Expenses |
6,633,364.07 |
| Deferred Income Tax Assets |
2,629,950.95 |
| Other Non-Current Assets |
355,503.70 |
| Sub-Total of Non-Current Assets |
484,449,669.86 |
| Total Assets |
1,659,524,388.53 |
| Short-Term Loans |
130,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
145,246,621.59 |
| Accounts Payable |
289,753,365.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,357,647.10 |
| Taxes Payable |
2,539,682.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,435,747.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,042,115.95 |
| Other Current Liabilities |
1,073,550.68 |
| Sub-Total of Current Liabilities |
611,706,813.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,751.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,196,108.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,214,231.33 |
| Total Liabilities |
630,921,044.50 |
| Paid-In Capital(Or Share Stock) |
134,400,000.00 |
| Capital Surplus |
479,787,412.72 |
| Surplus Reserve |
56,603,131.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
350,173,880.62 |
| Minority Stockholder's Interest |
16,376,018.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,012,227,325.05 |
| Owner's Equity（Stockholder's Equity） |
1,028,603,344.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,659,524,388.53 |
